Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Adjunct in the management of metabolic alkalosis. ## Adult Dosing * **Oral:** * **Prevention:** 20 mEq (1.5 g) to 40 mEq (3 g) per day, divided into 2-4 doses. * **Treatment:** 40 mEq (3 g) to 100 mEq (7.5 g) per day, divided into 4-10 doses. Maximum recommended daily dose is typically 200 mEq (15 g), but may be higher under close medical supervision. * **Intravenous (IV):** * **Treatment of Hypokalemia:** Dosing depends on serum potassium level, severity of symptoms, and ECG findings. Common initial doses range from 10 mEq to 40 mEq per dose. * **Maximum infusion rate:** Generally should not exceed 10 mEq/hour peripherally and 20 mEq/hour centrally, unless severe and life-threatening hypokalemia is present and being managed in a critical care setting with continuous ECG monitoring. * **Maximum concentration:** Peripheral IV: 40 mEq/L. Central IV: Up to 100 mEq/L (higher concentrations may be used in critical care settings with close monitoring). ## Pediatric Dosing * **Oral:** * **Maintenance:** 1 mEq/kg/day to 2 mEq/kg/day, not to exceed adult doses. * **Treatment:** 2 mEq/kg to 4 mEq/kg per dose, not to exceed adult doses. * **Intravenous (IV):** * **Treatment of Hypokalemia:** Dosing depends on serum potassium level and patient weight. Common initial doses range from 0.5 mEq/kg to 1 mEq/kg per dose. * **Maximum infusion rate:** Generally should not exceed 0.5 mEq/kg/hour (or 10 mEq/hour, whichever is less) for peripheral IVs, and 1 mEq/kg/hour (or 20 mEq/hour, whichever is less) for central IVs, unless severe and life-threatening hypokalemia is present and being managed in a critical care setting with continuous ECG monitoring. * **Maximum concentration:** 40 mEq/L for peripheral IVs. Higher concentrations may be used centrally with close monitoring. ## Dose Adjustments * **Renal Impairment:** Use with caution. Dosage reduction is often necessary. Monitor potassium levels closely. * **Adrenal Insufficiency:** Use with caution. ## Contraindications * Severe renal impairment. * Conditions that may lead to hyperkalemia (e.g., untreated Addison's disease, severe burns, crush injuries, extensive tissue breakdown, certain types of renal tubular acidosis). * Hyperkalemia. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal pain, GI bleeding or perforation (especially with sustained-release oral formulations and in patients with delayed GI transit). * **Cardiovascular:** Hypotension, arrhythmias, cardiac arrest (primarily with rapid IV administration or severe hyperkalemia). * **Other:** Hyperkalemia (can be asymptomatic or present with muscle weakness, paresthesias, confusion, cardiac abnormalities). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs:** May impair potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia can increase digoxin toxicity. ## Monitoring * Serum potassium levels. * Renal function (serum creatinine, BUN). * ECG, especially with IV administration or suspected hyperkalemia. * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of water to minimize GI upset. * Sustained-release oral formulations may cause intestinal obstruction or perforation. Use with caution in patients with slow intestinal transit. * IV potassium chloride must be administered slowly and diluted to prevent cardiac toxicity. Rapid infusion can be fatal. * Ensure adequate urine output before administering IV potassium. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.